The second dose of Johnson & Johnson Corona vaccine protects up to 94% of the body
The company has announced that the boost dose received two months after the first dose will increase the level of antibodies in the body by 4 to 6 times compared to the first dose, IRNA reported on Wednesday, Reuters reported. When this dose is injected 6 months after the first dose, the level of antibodies increases 12 times.
“One dose of our vaccine triggers a strong immune response to long-term immune memory, and when the booster (second dose) is injected, it protects the body against the odds,” said Johnson & Johnson, head of research and development at Johnson & Johnson. Covid-19 disease increases further.
The first dose of Johnson & Johnson vaccine boosts immunity by 75% and boosts the immune system by 94%.
Earlier this year, Johnson & Johnson said the first dose was 66 percent safe against mild Covid-19 and up to 85 percent safe for severe acute illness, according to CBS News.
According to the latest research, the second dose of the vaccine increases the level of antibodies in the body for all age groups, and the side effects are similar to those that appear after the first dose.
Johnson & Johnson said it would provide information to the US Food and Drug Administration and other drug regulators around the world to obtain a dual booster license for the vaccine.
According to CNBC, approximately 15 million Americans have received the first dose of their vaccine.
Johnson & Johnson’s announcement came Tuesday as U.S. officials continued to discuss boosting doses as a way to stop more contagious delta strains.
More than 675,000 Americans have died from Covid-19, the death toll from the Spanish flu epidemic of 1918 to 1919.
CNBC reports that the US Food and Drug Administration, an independent body, has recommended that a third dose of the Pfizer vaccine be given to people 65 and older who are at high risk for the disease after 6 months of the second dose. The US Food and Drug Administration is expected to announce its final decision in the coming days.
.